Publications in collaboration with researchers from Hospital Universitario de Donostia (1)

2021

  1. The pseudokinase TRIB3 negatively regulates the HER2 receptor pathway and is a biomarker of good prognosis in luminal breast cancer

    Cancers, Vol. 13, Núm. 21